蔓茎堇菜和柔毛堇菜多糖的抑菌抗氧化活性

利用乙醇沉淀法提取蔓茎堇菜Viola diffusa和柔毛堇菜V.principis多糖并分别进行抑菌及抗氧化试验。结果表明,蔓茎堇菜和柔毛堇菜多糖提取率分别为7.0%和8.3%。不同倍数体积无水乙醇沉淀提取的多糖抑菌和抗氧化能力不同。抑菌效果显示,蔓茎堇菜多糖对大肠杆菌和枯草芽孢杆菌的抑菌圈分别可达8.46mm和8.59mm,柔毛堇菜对大肠杆菌和枯草芽孢杆菌的抑菌圈均可达9.13mm,但两种堇菜多糖对黑曲霉和啤酒酵母未呈现抑制活性;抗氧化研究发现,蔓茎堇菜多糖抗氧化活性为243.64U·mL^-1,柔毛堇菜多糖抗氧化活性为411.78U·mL^-1。由此可见,无论是抑菌还是抗氧化活性方面,柔毛堇菜极显著优于蔓茎堇菜(P<0.01)。蔓茎堇菜和柔毛堇菜多糖都具有一定的抑菌抗氧化活性,均可作为食药两用植物资源进行开发利用。     

培土栽培对麻竹笋品质的影响机理研究

为了评价不同栽培模式对麻竹笋品质影响,提高竹林经济效益,采用培土栽培和不培土栽培两种方式,通过研究麻竹笋外观形态、营养物质、呈味物质及氨基酸含量,分析了不同培土栽培对麻竹笋品质的影响。结果表明:(1)培土栽培的麻竹笋个体重量、基茎、长度及可食率较不培土栽培竹笋分别显著提高了28.09%、12.76%、19.61%、23.53%,箨壁厚度显著降低了46.43%。(2)培土栽培的麻竹笋灰分、蛋白质、脂肪及淀粉含量较不培土栽培竹笋分别显著下降了10.08%、12.77%、26.09%、48.84%,而还原糖、可溶性糖、水分及维生素C含量均不同程度增加。(3)培土栽培的麻竹笋单宁、草酸、纤维素、木质素含量较不培土栽培竹笋分别下降26.32%、20.26%、39.12%、25.47%。(4)培土栽培的麻竹笋氨基酸总量较不培土栽培竹笋显著增加了26.08%,其中的苦味、芳香类和鲜味氨基酸含量占比均下降,但甜味氨基酸占比则显著上升。研究发现,培土栽培可以改善麻竹笋外观形态,同时增加竹笋甜味、减少粗糙度和酸涩味,从而使竹笋品质得到明显提升。     

ompC突变造成大肠杆菌在碱性条件下对渗透压敏感

大肠杆菌DH42突变株碱性条件下对高渗透压敏感。采用mini-Tn5转座突变质粒,同源重组构建突变菌株和DNA片段亚克隆等技术确定了造成大肠杆菌DH42在碱性条件下,对高渗透压敏感的原因是ompC基因突变。通过P1转导,构建了大肠杆菌D9（W3110 ompC：：kan）菌株。比较D9菌株和DH42菌株在不同pH和不同盐浓度条件下的生长,发现大肠杆菌ompC基因是大肠杆菌在碱性条件下应对高渗透压环境胁迫的必须基因。     

Biofunctionalized self-assembly of peptide amphiphile induces the differentiation of bone marrow mesenchymal stem cells into neural cells

Molecular and Cellular Biochemistry - Bone marrow mesenchymal stem cells (BMSCs) are multipotential differentiation cells which can differentiate into different cell types such as osteoblasts,...     

Multifunction of the ER P-Type Calcium Pump Spf1 During Hyphal Development in Candida albicans

Mycopathologia - Candida albicans is one of the most important fungal pathogens. Hyphal development is required for the virulence of this pathogen. Our previous study has revealed that Spf1, an ER...     

LncRNA NBR2 inhibits epithelial-mesenchymal transition by regulating Notch1 signaling in osteosarcoma cells

Long noncoding RNAs (lncRNAs) have been identified to have increasingly important roles in tumorigenesis, and they may serve as novel biomarkers for cancer therapy. Recent studies have demonstrated that lncRNA NBR2 (neighbor of BRCA1 gene 2), a novel identified lncRNA, is decreased in several cancers; however, the role of NBR2 in the development of osteosarcoma has not been elucidated. In our study, we found that NBR2 expression was downregulated in osteosarcoma tissues, and osteosarcoma cases with lower NBR2 expression exhibited a shorter overall survival time compared with those with higher NBR2 expression. NBR2 overexpression inhibited osteosarcoma cell proliferation, invasion, and migration but did not increase apoptosis. Furthermore, RNA-binding protein immunoprecipitation assays confirmed that NBR2 directly binds to Notch1 protein. Furthermore, overexpression of Notch1 in NBR2-overexpressing osteosarcoma cells reversed the effects of NBR2 on cell proliferation, invasion, migration, and epithelial-mesenchymal transition. The in vivo results showed that NBR2 overexpression inhibited tumor growth in nude mice that were inoculated with osteosarcoma cells. NBR2 overexpression also suppressed the messenger RNA (mRNA) expression of Notch1, N-cadherin, and vimentin and increased the mRNA expression of E-cadherin in the tumor tissues. These data indicated that NBR2 served as a tumor suppressor gene in osteosarcoma and inhibited osteosarcoma cell proliferation, invasion, and migration. The current study provides a novel insight and treatment strategy for osteosarcoma.